Wogonoside prevents colitis-associated colorectal carcinogenesis and colon cancer progression in inflammation-related microenvironment via inhibiting NF-κB activation through PI3K/Akt pathway

Yang Sun(China Pharmaceutical University), Na Lu(Jinan University)
Oncotarget
April 18, 2016
Cited by 55


Related Papers